Impaired motor competence in children with transplanted liver

Runar Almaas1, Unn Jensen, Marianne C Loennecken

  • 1*Department of Pediatric Research, Rikshospitalet, Oslo University Hospital †Institute of Health and Society, Medical Faculty, University of Oslo ‡Section for Transplantation Surgery, Department of Transplantation Medicine §Division of Surgery and Clinical Neuroscience, Department of Orthopaedics, Section of Research, Oslo University Hospital, Oslo, Norway.

Insights

Children undergoing liver transplantation show impaired motor skills, including ball skills and balance, compared to healthy peers. These deficits persist and do not improve over time post-transplant.

Area of Science:

  • Pediatric medicine
  • Transplantation surgery
  • Motor development

Background:

  • Cognitive function deficits are known after pediatric liver transplantation.
  • Limited data exist on motor competence in this population.

Purpose of the Study:

  • To assess motor competence in children after liver transplantation.
  • To compare their motor skills with healthy children.

Main Methods:

  • Movement Assessment Battery for Children (M-ABC) test administered to 35 children (4-12 years) post-liver transplant.
  • Comparison with a healthy reference group.

Main Results:

  • Children with liver transplants exhibited significantly worse M-ABC scores (P < 0.0001).
  • Impaired manual dexterity, ball skills, and balance were observed.
  • 29% of transplanted children had impaired motor competence versus 9% of controls.
  • Motor competence did not improve over time; ball skills worsened 4 years post-transplant.
  • Renal function predicted motor competence in children with cholestatic liver disease.

Conclusions:

  • Liver transplantation in children is associated with impaired motor competence.
  • Adverse development in ball skills occurs years after transplantation.
  • Motor skills do not improve post-transplant, with some areas declining.
  • Renal function is a key predictor of motor outcomes in specific pediatric liver transplant subgroups.
Abstract

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
266
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
782
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
367
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
364